326 related articles for article (PubMed ID: 25456101)
1. Development of human neutralizing monoclonal antibodies for prevention and therapy of MERS-CoV infections.
Ying T; Li H; Lu L; Dimitrov DS; Jiang S
Microbes Infect; 2015 Feb; 17(2):142-8. PubMed ID: 25456101
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing Monoclonal Antibodies as Promising Therapeutics against Middle East Respiratory Syndrome Coronavirus Infection.
Han HJ; Liu JW; Yu H; Yu XJ
Viruses; 2018 Nov; 10(12):. PubMed ID: 30513619
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants.
Tai W; Wang Y; Fett CA; Zhao G; Li F; Perlman S; Jiang S; Zhou Y; Du L
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795425
[TBL] [Abstract][Full Text] [Related]
4. A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV.
Zhao G; He L; Sun S; Qiu H; Tai W; Chen J; Li J; Chen Y; Guo Y; Wang Y; Shang J; Ji K; Fan R; Du E; Jiang S; Li F; Du L; Zhou Y
J Virol; 2018 Sep; 92(18):. PubMed ID: 29950421
[TBL] [Abstract][Full Text] [Related]
5. Ultrapotent Human Neutralizing Antibody Repertoires Against Middle East Respiratory Syndrome Coronavirus From a Recovered Patient.
Niu P; Zhang S; Zhou P; Huang B; Deng Y; Qin K; Wang P; Wang W; Wang X; Zhou J; Zhang L; Tan W
J Infect Dis; 2018 Sep; 218(8):1249-1260. PubMed ID: 29846635
[TBL] [Abstract][Full Text] [Related]
6. Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection.
Qiu H; Sun S; Xiao H; Feng J; Guo Y; Tai W; Wang Y; Du L; Zhao G; Zhou Y
Antiviral Res; 2016 Aug; 132():141-8. PubMed ID: 27312105
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of candidate vaccine approaches for MERS-CoV.
Wang L; Shi W; Joyce MG; Modjarrad K; Zhang Y; Leung K; Lees CR; Zhou T; Yassine HM; Kanekiyo M; Yang ZY; Chen X; Becker MM; Freeman M; Vogel L; Johnson JC; Olinger G; Todd JP; Bagci U; Solomon J; Mollura DJ; Hensley L; Jahrling P; Denison MR; Rao SS; Subbarao K; Kwong PD; Mascola JR; Kong WP; Graham BS
Nat Commun; 2015 Jul; 6():7712. PubMed ID: 26218507
[TBL] [Abstract][Full Text] [Related]
8. A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein.
Chen Y; Lu S; Jia H; Deng Y; Zhou J; Huang B; Yu Y; Lan J; Wang W; Lou Y; Qin K; Tan W
Emerg Microbes Infect; 2017 May; 6(5):e37. PubMed ID: 28536429
[TBL] [Abstract][Full Text] [Related]
9. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.
Li Y; Wan Y; Liu P; Zhao J; Lu G; Qi J; Wang Q; Lu X; Wu Y; Liu W; Zhang B; Yuen KY; Perlman S; Gao GF; Yan J
Cell Res; 2015 Nov; 25(11):1237-49. PubMed ID: 26391698
[TBL] [Abstract][Full Text] [Related]
10. Human neutralizing antibodies against MERS coronavirus: implications for future immunotherapy.
Tang XC; Marasco WA
Immunotherapy; 2015; 7(6):591-4. PubMed ID: 26098703
[No Abstract] [Full Text] [Related]
11. Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain.
Zhou Y; Yang Y; Huang J; Jiang S; Du L
Viruses; 2019 Jan; 11(1):. PubMed ID: 30646569
[TBL] [Abstract][Full Text] [Related]
12. Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection.
Houser KV; Gretebeck L; Ying T; Wang Y; Vogel L; Lamirande EW; Bock KW; Moore IN; Dimitrov DS; Subbarao K
J Infect Dis; 2016 May; 213(10):1557-61. PubMed ID: 26941283
[TBL] [Abstract][Full Text] [Related]
13. Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein.
Widjaja I; Wang C; van Haperen R; Gutiérrez-Álvarez J; van Dieren B; Okba NMA; Raj VS; Li W; Fernandez-Delgado R; Grosveld F; van Kuppeveld FJM; Haagmans BL; Enjuanes L; Drabek D; Bosch BJ
Emerg Microbes Infect; 2019; 8(1):516-530. PubMed ID: 30938227
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing the MERS coronavirus threat.
Haagmans BL; Osterhaus AD
Sci Transl Med; 2014 May; 6(235):235fs19. PubMed ID: 24807556
[TBL] [Abstract][Full Text] [Related]
15. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein.
Jiang L; Wang N; Zuo T; Shi X; Poon KM; Wu Y; Gao F; Li D; Wang R; Guo J; Fu L; Yuen KY; Zheng BJ; Wang X; Zhang L
Sci Transl Med; 2014 Apr; 6(234):234ra59. PubMed ID: 24778414
[TBL] [Abstract][Full Text] [Related]
16. A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice.
Niu P; Zhao G; Deng Y; Sun S; Wang W; Zhou Y; Tan W
Sci China Life Sci; 2018 Oct; 61(10):1280-1282. PubMed ID: 30091015
[No Abstract] [Full Text] [Related]
17. Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein.
Goo J; Jeong Y; Park YS; Yang E; Jung DI; Rho S; Park U; Sung H; Park PG; Choi JA; Seo SH; Cho NH; Lee H; Lee JM; Kim JO; Song M
Virus Res; 2020 Mar; 278():197863. PubMed ID: 31945421
[TBL] [Abstract][Full Text] [Related]
18. Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.
Chen Z; Bao L; Chen C; Zou T; Xue Y; Li F; Lv Q; Gu S; Gao X; Cui S; Wang J; Qin C; Jin Q
J Infect Dis; 2017 Jun; 215(12):1807-1815. PubMed ID: 28472421
[TBL] [Abstract][Full Text] [Related]
19. MERS-CoV spike protein: a key target for antivirals.
Du L; Yang Y; Zhou Y; Lu L; Li F; Jiang S
Expert Opin Ther Targets; 2017 Feb; 21(2):131-143. PubMed ID: 27936982
[TBL] [Abstract][Full Text] [Related]
20. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Infection, Immunological Response, and Vaccine Development.
Mubarak A; Alturaiki W; Hemida MG
J Immunol Res; 2019; 2019():6491738. PubMed ID: 31089478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]